Abstracts

TREATMENT OF ACUTE HIV INFECTION IN NEONATES

Antiretroviral therapy (ART) initiated soon after primary infection is thought to influence seeding of the viral reservoir with beneficial effects for virologic control. Infants are an important group who can be identified soon after infection. Here we describe virologic dynamics following early ART in infants. For the past 2 years, HIV PCR testing has been…

LOPINAVIR/RITONAVIR 1:1 SUPER-BOOSTING OVERCOMES RIFAMPICIN INTERACTIONS IN CHILDREN

Lopinavir/ritonavir 4:1 (LPV/r) is important in 1st-line antiretroviral therapy for infants. In high-burden settings, rifampicin based co-treatment for tuberculosis (TB) is often needed, but causes significant drug interactions. Superboosting LPV/r with ritonavir for a 1:1 ratio is considered effective, based on pharmacokinetic (PK) studies in 15 children. In an open-label, prospective study at 5 South…

HIV-1 RESISTANCE TO KF116 REVEALS INTEGRASE’S ROLE DURING POLYPROTEIN PROCESSING

The pyridine-based multimerization selective HIV-1 integrase (IN) inhibitors (MINIs) are a distinct sub-class of allosteric IN inhibitors. MINIs potently inhibit HIV-1 replication during virion maturation by inducing aberrant IN multimerization, while being ineffective during the early steps of viral replication. Here, we investigated the mechanism for evolution of a triple IN substitution (T124N/V165I/T174I) that emerges…

ECCENTRIC VIRAL GENOMIC RNA AND INTEGRASE ARE PREMATURELY DEGRADED IN TARGET CELLS

Recent evidence indicates that inhibition of HIV-1 integrase (IN) binding to the viral RNA genome yields aberrant particles, in which the viral ribonucleoprotein complexes (vRNPs) are eccentrically localized outside the protective capsid core. These particles are non-infectious and blocked at an early reverse transcription stage in target cells. However, the basis of this reverse transcription…